Published in Lancet on September 05, 2005
Unacceptably high mortality related to measles epidemics in Niger, Nigeria, and Chad. PLoS Med (2007) 2.59
Cost-effectiveness analysis of insecticide-treated net distribution as part of the Togo Integrated Child Health Campaign. Malar J (2008) 1.95
An evaluation of infant immunization in Africa: is a transformation in progress? Bull World Health Organ (2007) 1.58
Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol (2006) 1.35
System-level determinants of immunization coverage disparities among health districts in Burkina Faso: a multiple case study. BMC Int Health Hum Rights (2009) 1.10
Accelerated measles control in sub-Saharan Africa. Lancet (2006) 1.09
Measles still has a devastating impact in unvaccinated populations. PLoS Med (2007) 1.06
The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open (2012) 1.04
Validating child vaccination status in a demographic surveillance system using data from a clinical cohort study: evidence from rural South Africa. BMC Public Health (2011) 1.02
Biological feasibility of measles eradication. J Infect Dis (2011) 1.01
Measles virus strain diversity, Nigeria and Democratic Republic of the Congo. Emerg Infect Dis (2010) 0.95
Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination. Viral Immunol (2012) 0.94
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Assessment of measles immunity among infants in Maputo City, Mozambique. BMC Public Health (2008) 0.87
Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy. Vaccine (2014) 0.86
The human story. BMJ (2005) 0.85
Yellow fever control in Cameroon: where are we now and where are we going? BMC Med (2008) 0.84
Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years. Vaccine (2012) 0.82
Measles in a tertiary institution in bida, niger state, Nigeria: prevalence, immunization status and mortality pattern. Oman Med J (2011) 0.82
Adding interventions to mass measles vaccinations in India. Bull World Health Organ (2016) 0.79
Vaccination and All-Cause Child Mortality From 1985 to 2011: Global Evidence From the Demographic and Health Surveys. Am J Epidemiol (2015) 0.78
Sun protection to improve vaccine effectiveness in children in a high ambient ultraviolet radiation and rural environment: an intervention study. BMC Public Health (2017) 0.75
Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013. Public Health Rep (2014) 0.75
Reaching the unreached with measles vaccination. Lancet (2005) 0.75
A 'post-honeymoon' measles epidemic in Burundi: mathematical model-based analysis and implications for vaccination timing. PeerJ (2016) 0.75
Comparison of LiST measles mortality model and WHO/IVB measles model. BMC Public Health (2011) 0.75
Viability and isolation of marine bacteria by dilution culture: theory, procedures, and initial results. Appl Environ Microbiol (1993) 5.09
One or more bound planets per Milky Way star from microlensing observations. Nature (2012) 4.68
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med (1995) 4.38
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol (1995) 4.11
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med (2000) 3.98
Deaths and injuries caused by land mines in Mozambique. Lancet (1995) 3.57
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis (1992) 3.37
Nurses taking on junior doctors' work: a confusion of accountability. BMJ (1996) 2.88
Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int (2007) 2.87
Instrumentation of the airway in the absence of intravenous access. Paediatr Anaesth (2003) 2.73
Calcium-dependent protein kinases play an essential role in a plant defence response. EMBO J (2001) 2.53
Can prosody aid the automatic classification of dialog acts in conversational speech? Lang Speech (2000) 2.51
Treating sexually abused children with posttraumatic stress symptoms: a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2000) 2.33
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (1996) 2.30
The organization of the araBAD operon of Escherichia coli. Gene (1986) 2.16
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat Med (1999) 2.11
Factors related to immunization status among inner-city Latino and African-American preschoolers. Pediatrics (1995) 2.08
Evidence-based recommendations for the use of Negative Pressure Wound Therapy in traumatic wounds and reconstructive surgery: steps towards an international consensus. Injury (2011) 2.07
Cause of death and correlation with autopsy findings in burns patients. Burns (2012) 2.07
CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods (1994) 2.01
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
The Use of a Helium-Oxygen Mixture during Maximum Expiratory Flow to Demonstrate Obstruction in Small Airways in Smokers. J Clin Invest (1975) 1.93
Laparoscopically assisted vaginal hysterectomy superfluous? S Afr Med J (1998) 1.92
Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology (2012) 1.92
The relationships between interphase Schwann cells and axons before myelination: a quantitative electron microscopic study. Dev Biol (1973) 1.91
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
Axillary plexus block using a peripheral nerve stimulator: single or multiple injections. Can J Anaesth (1992) 1.87
Intermediate filament interactions can be altered by HSP27 and alphaB-crystallin. J Cell Sci (1999) 1.87
Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol (2001) 1.86
Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (1995) 1.85
Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 1.81
Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology (1999) 1.80
Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest (1982) 1.74
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. Mult Scler (2012) 1.74
CD4+CD28- costimulation-independent T cells in multiple sclerosis. J Clin Invest (2001) 1.74
[Nucleotide sequence determination of yeast mitochondrial phenylalanine-tRNA]. C R Acad Sci Hebd Seances Acad Sci D (1978) 1.73
A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain (2009) 1.69
Declining financial capacity in mild cognitive impairment: A 1-year longitudinal study. Neurology (2009) 1.69
Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J Exp Med (1984) 1.68
Rotavirus epidemiology in Vellore, south India: group, subgroup, serotype, and electrophoretype. J Clin Microbiol (1988) 1.60
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology (1988) 1.53
Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood (1986) 1.53
[Age dependence of laboratory parameters in a health study--attempt at calculating a laboratory index for assessing biological aging]. Z Gerontol Geriatr (2002) 1.53
A systematic approach to spinal reconstruction after anterior decompression for neoplastic disease of the thoracic and lumbar spine. Neurosurgery (1993) 1.52
Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium. J Invest Dermatol (1997) 1.52
Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol (2008) 1.51
Estrogen receptor: a prognostic factor in breast cancer. Cancer (1981) 1.51
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg (2001) 1.50
Carbon substrate utilization studies of some cultures of Alcaligenes denitrificans, Alcaligenes faecalis, and Alcaligenes odorans isolated from clinical specimens. J Clin Microbiol (1978) 1.48
Increased systemic availability of albendazole when taken with a fatty meal. Eur J Clin Pharmacol (1988) 1.48
Atracurium and vecuronium interaction with gentamicin and tobramycin. Can J Anaesth (1989) 1.47
Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med (1976) 1.46
Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (2011) 1.46
Complex visual disturbances in Alzheimer's disease. Neurology (1990) 1.45
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J Immunol (1998) 1.44
Use of overpressure to assess the role of bubbles in focused ultrasound lesion shape in vitro. Ultrasound Med Biol (2001) 1.44
Mapping and complementation studies of the gene for release factor 1. J Bacteriol (1986) 1.43
Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest (2001) 1.43
Interactions within the yeast Sm core complex: from proteins to amino acids. Mol Cell Biol (1998) 1.42
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41
[Videolaryngoscopy, for everybody?]. Ann Fr Anesth Reanim (2012) 1.40
Demonstration of epidermal transfer from a polymer membrane using genetically marked porcine keratinocytes. Burns (2001) 1.40
Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors. Nat Struct Biol (1999) 1.40
Monitoring the frequency of side effects of drugs. Reasons for stopping drugs could be recorded in general practice. BMJ (1996) 1.39
Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med (1999) 1.39
Clinical, electrical and mechanical correlations during recovery from neuromuscular blockade with vecuronium. Can J Anaesth (1990) 1.38
Characterization of some groups of gram-negative nonfermentative bacteria by the carbon source alkalinization technique. J Clin Microbiol (1981) 1.37
A new global framework for immunization monitoring and surveillance. Bull World Health Organ (2007) 1.36
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother (1995) 1.35
Cryptic peripheral ribosomal domains distributed intermittently along mammalian myelinated axons. J Neurosci (2000) 1.35
Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events. J Immunol (1999) 1.34
Increasing immunization rates among inner-city, African American children. A randomized trial of case management. JAMA (1998) 1.33
Evidence-based recommendations for negative pressure wound therapy: treatment variables (pressure levels, wound filler and contact layer)--steps towards an international consensus. J Plast Reconstr Aesthet Surg (2011) 1.33
Single-tube and nested reverse transcriptase-polymerase chain reaction for detection of Rift Valley fever virus in human and animal sera. J Virol Methods (2001) 1.33
Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol (1994) 1.32
A guide to biological skin substitutes. Br J Plast Surg (2002) 1.32
In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. J Antimicrob Chemother (1986) 1.32
Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors. Mol Cell Neurosci (2002) 1.31
Morphometry of the human cortex cerebri and corpus striatum during aging. Neurobiol Aging (1992) 1.28
Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol (1999) 1.27
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells. Leukemia (2012) 1.25
Long-term methadone maintenance therapy: effects on liver function. Ann Intern Med (1972) 1.23
Nosocomial transmission of measles: an updated review. Vaccine (2012) 1.23
Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain (2003) 1.22
Context effects on misreading and suppression at UAG codons in human cells. Mol Cell Biol (1995) 1.22
Total UK multi-centre experience with a novel arterial occlusion device (Duct Occlud pfm). Heart (1996) 1.22
Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol (2001) 1.21
Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis (1995) 1.21
Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry (2000) 1.21
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother (1996) 1.20
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
The terminal crest: morphological features relevant to electrophysiology. Heart (2002) 1.20
Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol (2001) 1.20
Progress toward control of rubella and prevention of congenital rubella syndrome--worldwide, 2009. J Infect Dis (2011) 1.20